JP2014517005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014517005A5 JP2014517005A5 JP2014514545A JP2014514545A JP2014517005A5 JP 2014517005 A5 JP2014517005 A5 JP 2014517005A5 JP 2014514545 A JP2014514545 A JP 2014514545A JP 2014514545 A JP2014514545 A JP 2014514545A JP 2014517005 A5 JP2014517005 A5 JP 2014517005A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cys
- thr
- lys
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161493868P | 2011-06-06 | 2011-06-06 | |
| US61/493,868 | 2011-06-06 | ||
| US201261625578P | 2012-04-17 | 2012-04-17 | |
| US61/625,578 | 2012-04-17 | ||
| PCT/US2012/040857 WO2012170392A2 (en) | 2011-06-06 | 2012-06-05 | Shk-based pharmaceutical compositions and methods of manufacturing and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017133701A Division JP2018008955A (ja) | 2011-06-06 | 2017-07-07 | Ｓｈｋベースの薬学的組成物とその製造方法および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014517005A JP2014517005A (ja) | 2014-07-17 |
| JP2014517005A5 true JP2014517005A5 (https=) | 2016-10-27 |
| JP6250536B2 JP6250536B2 (ja) | 2017-12-20 |
Family
ID=47296695
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514545A Expired - Fee Related JP6250536B2 (ja) | 2011-06-06 | 2012-06-05 | Ｓｈｋベースの薬学的組成物とその製造方法および使用方法 |
| JP2017133701A Withdrawn JP2018008955A (ja) | 2011-06-06 | 2017-07-07 | Ｓｈｋベースの薬学的組成物とその製造方法および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017133701A Withdrawn JP2018008955A (ja) | 2011-06-06 | 2017-07-07 | Ｓｈｋベースの薬学的組成物とその製造方法および使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9381261B2 (https=) |
| EP (2) | EP3263123A3 (https=) |
| JP (2) | JP6250536B2 (https=) |
| KR (1) | KR20140038501A (https=) |
| CN (1) | CN103687608B (https=) |
| AU (2) | AU2012268441B2 (https=) |
| BR (1) | BR112013031370A2 (https=) |
| CA (1) | CA2838474A1 (https=) |
| MX (1) | MX351353B (https=) |
| RU (1) | RU2637085C2 (https=) |
| SG (2) | SG10201604468QA (https=) |
| TW (2) | TW201542231A (https=) |
| WO (1) | WO2012170392A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012170392A2 (en) | 2011-06-06 | 2012-12-13 | Kineta One, Llc | Shk-based pharmaceutical compositions and methods of manufacturing and using the same |
| EP3024472A4 (en) * | 2013-07-22 | 2017-06-28 | Kineta One, LLC | Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof |
| JP6847828B2 (ja) * | 2014-08-15 | 2021-03-24 | モナッシュ ユニバーシティ | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
| LT3288379T (lt) | 2015-05-01 | 2022-02-25 | Onl Therapeutics, Inc. | Peptidų kompozicijos ir naudojimo būdai |
| KR102533290B1 (ko) * | 2022-04-14 | 2023-05-16 | 한국해양과학기술원 | 전압개폐 칼륨이온채널 억제 활성능을 갖는 펩타이드 |
| KR102553070B1 (ko) * | 2022-06-16 | 2023-07-07 | 한국해양과학기술원 | 전압개폐 칼륨이온채널 억제 활성능을 갖는 작은상자해파리 기원 펩타이드 |
| WO2026003546A1 (en) | 2024-06-27 | 2026-01-02 | Vrg Miniprotein Zrt | Potassium ion kv1.3 channel inhibitors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4353888A (en) | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
| US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
| US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| DE3829766A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Verfahren zur herstellung von membranen |
| DE3829752A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
| US5084350A (en) | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
| CA2109085C (en) | 1991-04-25 | 2003-03-11 | Keith E. Dionne | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| ATE218893T1 (de) | 1993-08-12 | 2002-06-15 | Neurotech Sa | Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten |
| AU7093396A (en) * | 1995-09-07 | 1997-03-27 | Elan Medical Technologies Limited | Medicament conversion system |
| WO1998023639A2 (en) * | 1996-11-27 | 1998-06-04 | University Of Florida | ShK TOXIN COMPOSITIONS AND METHODS OF USE |
| WO1999013895A1 (en) | 1997-09-17 | 1999-03-25 | University Of Florida | Polypeptide compositions that inhibit potassium channel activity and uses therefor |
| EP0953576B1 (en) * | 1998-04-30 | 2005-11-02 | Curis, Inc. | Active hedgehog protein conjugate, process for its production and use |
| EP2474316B1 (en) | 2004-10-07 | 2016-04-06 | The Regents of The University of California | Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels |
| US7833979B2 (en) | 2005-04-22 | 2010-11-16 | Amgen Inc. | Toxin peptide therapeutic agents |
| EP1904130B1 (en) | 2005-06-21 | 2016-03-30 | Eli Lilly And Company | Needled pharmaceutical delivery device with triggered automatic needle insertion and manually controlled pharmaceutical injection |
| US20110163469A1 (en) | 2005-12-16 | 2011-07-07 | Massachusetts Institute Of Technology | High-throughput fabrication of microparticles |
| WO2009021289A1 (en) | 2007-08-14 | 2009-02-19 | The Walter And Eliza Hall Institute Of Medical Research | Potassium channel inhibitors |
| US8722079B2 (en) | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
| EP2408814B1 (en) * | 2009-03-20 | 2018-11-21 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
| WO2012170392A2 (en) | 2011-06-06 | 2012-12-13 | Kineta One, Llc | Shk-based pharmaceutical compositions and methods of manufacturing and using the same |
| IN2014CN03333A (https=) * | 2011-10-03 | 2015-07-03 | Univ California | |
| US20160338967A1 (en) * | 2013-12-23 | 2016-11-24 | Kineta One, Llc | Sustained release depot formulations of therapeutic proteins, and uses thereof |
-
2012
- 2012-06-05 WO PCT/US2012/040857 patent/WO2012170392A2/en not_active Ceased
- 2012-06-05 RU RU2013157823A patent/RU2637085C2/ru not_active IP Right Cessation
- 2012-06-05 TW TW104110742A patent/TW201542231A/zh unknown
- 2012-06-05 BR BR112013031370A patent/BR112013031370A2/pt not_active IP Right Cessation
- 2012-06-05 MX MX2013014401A patent/MX351353B/es active IP Right Grant
- 2012-06-05 SG SG10201604468QA patent/SG10201604468QA/en unknown
- 2012-06-05 US US14/124,669 patent/US9381261B2/en active Active - Reinstated
- 2012-06-05 AU AU2012268441A patent/AU2012268441B2/en not_active Ceased
- 2012-06-05 JP JP2014514545A patent/JP6250536B2/ja not_active Expired - Fee Related
- 2012-06-05 SG SG2013089842A patent/SG195302A1/en unknown
- 2012-06-05 TW TW101120237A patent/TWI535455B/zh not_active IP Right Cessation
- 2012-06-05 EP EP17175832.9A patent/EP3263123A3/en not_active Withdrawn
- 2012-06-05 EP EP12797181.0A patent/EP2717899A4/en not_active Withdrawn
- 2012-06-05 CN CN201280035051.7A patent/CN103687608B/zh not_active Expired - Fee Related
- 2012-06-05 CA CA2838474A patent/CA2838474A1/en not_active Abandoned
- 2012-06-05 KR KR1020147000102A patent/KR20140038501A/ko not_active Ceased
-
2015
- 2015-08-26 US US14/836,700 patent/US9878058B2/en active Active
-
2016
- 2016-07-01 US US15/201,209 patent/US20160331847A1/en not_active Abandoned
- 2016-07-29 AU AU2016208422A patent/AU2016208422A1/en not_active Abandoned
-
2017
- 2017-07-07 JP JP2017133701A patent/JP2018008955A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6786731B2 (ja) | 二重標的イメージング用分子プローブ及びその調製方法と応用 | |
| JP2014517005A5 (https=) | ||
| RU2594167C2 (ru) | Композиции пептидных радиоактивных индикаторов | |
| AU2019216714A1 (en) | Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer | |
| Santos-Cuevas et al. | Design, preparation, in vitro and in vivo evaluation of 99mTc-N2S2-Tat (49–57)-bombesin: a target-specific hybrid radiopharmaceutical | |
| BR112020018155A2 (pt) | 177lu-dota-hynic-ipsma como um radiofármaco terapêutico dirigido ao antígeno prostático específico de membrana | |
| KR101550006B1 (ko) | 췌도 이미징용 분자 프로브 및 그 사용 | |
| JP2024045148A (ja) | 放射性医薬品用のソマトスタチンアナログを含む組成物 | |
| Faintuch et al. | Radiolabeled NGR phage display peptide sequence for tumor targeting | |
| TWI535455B (zh) | 以ｓｈｋ為主之醫藥組合物及其製備方法及用途 | |
| EP4146268A2 (en) | Methods of detecting and treating lung damage in respiratory-related viral infections | |
| EP2680888B1 (en) | Technetium labelled peptides | |
| RU2505316C2 (ru) | Способ визуализации | |
| AU2010258599B2 (en) | PET imaging of fibrogenesis | |
| Ghorbantabar Omrani et al. | Preparation and Radiochemical Evaluation of 99mTc-HYNIC-[Lys3, Tyr4] bombesin (3-14) for Prostate Cancer Detection |